Vaxxinity Inc.
0.00
-0.00 (-100.00%)
At close: Jan 15, 2025, 2:30 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -56.93M -75.22M -137.18M -39.96M -14.22M
Depreciation & Amortization 2.23M 1.68M 1.10M 717.00K 107.00K
Stock-Based Compensation 7.51K 8.71M 30.41M 1.01M 1.23M
Other Working Capital -5.03M 7.72M 2.25M -2.25M 603.00K
Other Non-Cash Items 6.00M -926.00K 3.21M 6.45M 462.00K
Deferred Income Tax n/a n/a 8.58M 656.00K n/a
Change in Working Capital -8.54M 9.82M 12.88M -2.79M 157.00K
Operating Cash Flow -57.24M -55.93M -80.99M -33.91M -12.27M
Capital Expenditures -803.00K -1.87M -1.32M -1.48M n/a
Acquisitions n/a 52.53M n/a n/a n/a
Purchase of Investments -63.94M -107.53M n/a n/a n/a
Sales Maturities Of Investments 93.59M 55.00M n/a n/a n/a
Other Investing Acitivies n/a -52.53M n/a n/a n/a
Investing Cash Flow 28.84M -54.39M -1.32M -1.48M n/a
Debt Repayment -1.59M -430.00K -771.00K 6.59M 11.12M
Common Stock Repurchased n/a n/a n/a -41.00K n/a
Dividend Paid n/a n/a n/a n/a n/a
Other Financial Acitivies 454.00K 263.00K 125.86M 59.51M 17.00K
Financial Cash Flow -1.14M -167.00K 196.17M 66.11M 11.14M
Net Cash Flow -29.53M -110.49M 113.86M 30.72M -1.13M
Free Cash Flow -58.04M -57.79M -82.31M -35.39M -12.27M